Grifols (GRFS) Change in Inventory (2009 - 2020)
Grifols (GRFS) posted Change in Inventory of -$82.4 million for Q1 2020, up 70.56% quarter-over-quarter from -$280.1 million in Q4 2019, and up 45.15% year-on-year from -$56.8 million in Q2 2019.
Grifols (GRFS) Change in Inventory (2009 - 2020) Analysis & Trends
Grifols (GRFS) has reported Change in Inventory for 10 consecutive years, with -$82.4 million the latest figure, recorded in Q1 2020.
- Change in Inventory for Q1 2020 came in at -$82.4 million, up 45.15% year-over-year; the trailing twelve-month figure through Mar 2020 was -$305.9 million (down 187.56% YoY), and the FY2025 annual result was -$112.9 million, down 506.4% from the prior year.
- Change in Inventory was -$82.4 million for Q1 2020 at Grifols, up from -$280.1 million in the prior quarter.
- Over five years, Change in Inventory peaked at $206.9 million in Q4 2018 and troughed at -$301.5 million in Q3 2016.
- Average Change in Inventory over 5 years is -$54.9 million, with a median of -$29.6 million recorded in 2016.
- Year-over-year, Change in Inventory jumped 530.79% in 2017 and sank 5685.14% in 2018.
- Over 5 years, Change in Inventory stood at -$29.6 million in 2016, then surged by 530.79% to $127.6 million in 2017, then soared by 62.12% to $206.9 million in 2018, then slumped by 235.34% to -$280.1 million in 2019, then jumped by 70.56% to -$82.4 million in 2020.
- Per Business Quant data, the three most recent Change in Inventory figures were -$82.4 million in Q1 2020, -$280.1 million in Q4 2019, and -$150.3 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 431.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 184.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -18.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 52.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -82.45 Mn |
| Mar 31, 2020 | -82.45 Mn |
| Dec 31, 2019 | -280.06 Mn |
| Dec 31, 2019 | -280.06 Mn |
| Mar 31, 2019 | -150.30 Mn |
| Mar 31, 2019 | -150.30 Mn |
| Dec 31, 2018 | 206.94 Mn |
| Dec 31, 2018 | 206.94 Mn |
| Jun 30, 2018 | -266.03 Mn |
| Jun 30, 2018 | -266.03 Mn |
| Mar 31, 2018 | 103.03 Mn |
| Mar 31, 2018 | 103.03 Mn |
| Dec 31, 2017 | 127.65 Mn |
| Dec 31, 2017 | 127.65 Mn |
| Jun 30, 2017 | 4.76 Mn |
| Jun 30, 2017 | 4.76 Mn |
| Mar 31, 2017 | 63.80 Mn |
| Mar 31, 2017 | 63.80 Mn |
| Dec 31, 2016 | -29.63 Mn |
| Dec 31, 2016 | -29.63 Mn |